News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,682 Results
Type
Article (40902)
Company Profile (267)
Press Release (680503)
Multimedia
Podcasts (81)
Webinars (17)
Section
Business (204664)
Career Advice (2023)
Deals (35532)
Drug Delivery (110)
Drug Development (81380)
Employer Resources (173)
FDA (16409)
Job Trends (14944)
News (346378)
Policy (32725)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2567)
Accelerated approval (32)
Adcomms (24)
Allergies (142)
Alliances (49575)
ALS (169)
Alzheimer's disease (1667)
Antibody-drug conjugate (ADC) (309)
Approvals (16678)
Artificial intelligence (514)
Autoimmune disease (153)
Automation (39)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (189)
Biotechnology (174)
Bladder cancer (157)
Brain cancer (56)
Breast cancer (638)
Cancer (4798)
Cardiovascular disease (398)
Career advice (1708)
Career pathing (36)
CAR-T (282)
CDC (44)
Celiac Disease (2)
Cell therapy (743)
Cervical cancer (36)
Clinical research (69559)
Collaboration (1699)
Company closure (4)
Compensation (1157)
Complete response letters (54)
COVID-19 (2710)
CRISPR (88)
C-suite (841)
Cystic fibrosis (143)
Data (6217)
Decentralized trials (2)
Denatured (25)
Depression (131)
Diabetes (500)
Diagnostics (6687)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (252)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (231)
Earnings (90166)
Editorial (57)
Employer branding (21)
Employer resources (152)
Events (117270)
Executive appointments (971)
FDA (19520)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1465)
Gene editing (194)
Generative AI (43)
Gene therapy (594)
GLP-1 (966)
Government (4659)
Grass and pollen (6)
Guidances (383)
Healthcare (18872)
HIV (58)
Huntington's disease (44)
IgA nephropathy (83)
Immunology and inflammation (249)
Immuno-oncology (57)
Indications (110)
Infectious disease (2978)
Inflammatory bowel disease (187)
Inflation Reduction Act (14)
Influenza (116)
Intellectual property (248)
Interviews (315)
IPO (16642)
IRA (50)
Job creations (3642)
Job search strategy (1428)
JPM (57)
Kidney cancer (16)
Labor market (85)
Layoffs (546)
Leadership (31)
Legal (7949)
Liver cancer (91)
Longevity (14)
Lung cancer (646)
Lymphoma (376)
Machine learning (42)
Management (59)
Manufacturing (792)
MASH (163)
Medical device (13768)
Medtech (13821)
Mergers & acquisitions (19960)
Metabolic disorders (1266)
Multiple sclerosis (160)
NASH (16)
Neurodegenerative disease (314)
Neuropsychiatric disorders (88)
Neuroscience (2891)
Neurotech (1)
NextGen: Class of 2026 (6519)
Non-profit (4514)
Now hiring (67)
Obesity (594)
Opinion (257)
Ovarian cancer (166)
Pain (197)
Pancreatic cancer (226)
Parkinson's disease (279)
Partnered (33)
Patents (494)
Patient recruitment (489)
Peanut (56)
People (58863)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21683)
Phase 2 (30613)
Phase 3 (22807)
Pipeline (5269)
Policy (281)
Postmarket research (2564)
Preclinical (9196)
Press Release (64)
Prostate cancer (237)
Psychedelics (48)
Radiopharmaceuticals (279)
Rare diseases (831)
Real estate (5954)
Recruiting (70)
Regulatory (24478)
Reports (52)
Research institute (2387)
Resumes & cover letters (352)
Rett syndrome (27)
RNA editing (16)
RSV (77)
Schizophrenia (148)
Series A (238)
Series B (190)
Service/supplier (11)
Sickle cell disease (95)
Special edition (21)
Spinal muscular atrophy (157)
Sponsored (41)
Startups (3614)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (84)
The Weekly (54)
Vaccines (1002)
Venture capital (88)
Weight loss (380)
Women's health (91)
Worklife (18)
Date
Today (117)
Last 7 days (606)
Last 30 days (2113)
Last 365 days (29910)
2026 (3412)
2025 (30172)
2024 (35215)
2023 (40075)
2022 (51174)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32108)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (736)
Alabama (83)
Alaska (7)
Arizona (309)
Arkansas (13)
Asia (39221)
Australia (6409)
California (11281)
Canada (3284)
China (1099)
Colorado (477)
Connecticut (475)
Delaware (336)
Europe (84509)
Florida (1687)
Georgia (355)
Hawaii (3)
Idaho (61)
Illinois (859)
India (65)
Indiana (519)
Iowa (22)
Japan (429)
Kansas (126)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1380)
Massachusetts (8078)
Michigan (324)
Minnesota (628)
Mississippi (5)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (78)
New Jersey (2999)
New Mexico (28)
New York (2972)
North Carolina (1449)
North Dakota (8)
Northern California (5513)
Ohio (332)
Oklahoma (21)
Oregon (41)
Pennsylvania (2275)
Puerto Rico (24)
Rhode Island (47)
South America (1108)
South Carolina (66)
South Dakota (1)
Southern California (4389)
Tennessee (174)
Texas (1739)
United States (39970)
Utah (334)
Vermont (1)
Virginia (260)
Washington D.C. (81)
Washington State (918)
West Virginia (4)
Wisconsin (108)
Wyoming (2)
721,682 Results for "genprex inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Genprex Provides Clinical Update on Diabetes Gene Therapy Program
January 7, 2026
·
8 min read
Press Releases
Genprex Announces IP Australia’s Intent to Grant Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
February 10, 2026
·
8 min read
Press Releases
Genprex Announces Positive Preliminary Preclinical Data from Study of GPX-002 in Type 2 Diabetic Animal Studies
January 6, 2026
·
10 min read
Press Releases
Genprex Adds Clinical Trial Site for Acclaim-1 and Acclaim-3 Lung Cancer Clinical Trials
November 20, 2025
·
8 min read
Press Releases
Data from Genprex’s Acclaim-1 Phase 1 Gene Therapy Clinical Trial Published in Clinical Lung Cancer
November 24, 2025
·
8 min read
Press Releases
Genprex Announces U.S. Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
November 19, 2025
·
7 min read
Press Releases
Genprex Announces European Patent Office’s Intent to Grant a Patent for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer
November 5, 2025
·
7 min read
Press Releases
Genprex Announces Registered Direct Offering of up to $10.0 Million Priced At-The-Market Under Nasdaq Rules
October 29, 2025
·
6 min read
Press Releases
Genprex Announces Registered Direct Offering of up to $8.1 Million Priced At-The-Market Under Nasdaq Rules
October 24, 2025
·
6 min read
Press Releases
Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 28, 2025
·
7 min read
1 of 72,169
Next
